MNSO
MINISO Group Holding Limited
There isn't enough reported data to score MNSO yet.
RIVN
Rivian Automotive, Inc.
RIVN lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
MNSO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Stable | |
| Strong |
MNSO's revenue and balance sheet are currently healthy, and its profitability and cash flow are stable.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MNSO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $9.54 | -13% |
| Current | 18x | $10.94 | — |
| Fair | 20x | $12.49 | +14% |
| Expensive | 49x | $29.81 | +173% |
Historical ranges are pointers, not guarantees.
MNSO's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
MNSO Forward outlook
There aren't enough analyst estimates for MNSO to show an outlook.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MNSO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.61 | -46% |
| Q1 2026 | $0.99 | -16% |
| Q4 2025 | $0.58 | -54% |
| Q3 2025 | $1.04 | -12% |
| Q2 2025 | $1.13 | -2.6% |
| Q1 2025 | $1.18 | +3.5% |
| Q4 2024 | $1.26 | +19% |
| Q3 2024 | $1.18 | +40% |
MNSO has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
MNSO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $869.5M | +17% |
| Q1 2026 | $848.5M | +28% |
| Q4 2025 | $925.6M | +31% |
| Q3 2025 | $869.9M | +28% |
| Q2 2025 | $745.3M | +23% |
| Q1 2025 | $664.4M | +19% |
| Q4 2024 | $707.2M | +23% |
| Q3 2024 | $678.7M | +19% |
MNSO has the edge over RIVN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 13% | -2.8 points |
| Q1 2026 | 12% | -3.4 points |
| Q4 2025 | 14% | -6.6 points |
| Q3 2025 | 14% | -4 points |
| Q2 2025 | 16% | -2.9 points |
| Q1 2025 | 16% | -4.4 points |
| Q4 2024 | 20% | +0.4 points |
| Q3 2024 | 18% | -2.8 points |
MNSO has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN's revenue is growing: $2.2B last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
MNSO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
| Q2 2024 | $0 | $0 |
RIVN has the stronger cash trend. Its trailing FCF is down 2.1% versus its history, compared with MNSO at down 100%.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
MNSO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +3.1M shares |
| 1 year | +0.1% | +218K shares |
| 3 years | -1.2% | -3.9M shares |
| 5 years | +6.6% | +19.3M shares |
| Available history | -1.3% | -4.2M shares |
MNSO has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
MNSO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 2.5x | Moderate |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | 0.7x | Very low |
| Q4 2024 | -0.9x | Net Cash |
| Q3 2024 | 0.1x | Very low |
MNSO's net debt is less than a year of its operating earnings (EBITDA).
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MNSO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.6 | Neutral |
| Stochastic | 50.4 | Neutral |
MNSO's weekly RSI is 45 (neutral) and its Stochastic is 50 (neutral).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
MNSO PE vs Consumer Cyclical Sector
| Metric | MNSO | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.1% above |
| PE % | 34 | 48 | 14 pts below |
MNSO is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
MNSO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.96 | 9.8% above |
| 20 week MA | $10.7 | 2.2% above |
| 50 week MA | $14.3 | 23% below |
| 100 week MA | $17.5 | 37% below |
| 200 week MA | $18.6 | 41% below |
MNSO has the edge over RIVN on trend strength, trading above more of its moving averages.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
MNSO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $23.2 | $31.0 | +34% |
| 2021 | $31.0 | $10.1 | -68% |
| 2022 | $10.1 | $11.3 | +12% |
| 2023 | $11.3 | $20.4 | +81% |
| 2024 | $20.4 | $24.1 | +18% |
| 2025 | $24.1 | $19.6 | -18% |
| 2026 YTD | $19.6 | $10.9 | -44% |
MNSO is down 44% so far in 2026, after finishing higher in four of the previous six years.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has the edge over MNSO on returns for 2026, with the stronger performance.